Last reviewed · How we verify
NCT06219551
Smoking Cessation Support for Patients With Rheumatologic Diseases Via WhatsApp
NA trial testing Mobile messages via What's App in Tobacco Use Cessation in 220 participants. Terminated before completion.
1 May 2025
Quick facts
| Lead sponsor | Recep Tayyip Erdogan University Training and Research Hospital |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 220 |
| Start date | 10 November 2023 |
| Primary completion | 1 May 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Mobile messages via What's App
Conditions studied
- Tobacco Use Cessation — all drugs for Tobacco Use Cessation →
Sponsor
Recep Tayyip Erdogan University Training and Research Hospital
Who can join
Adults 18 to 80, any sex, with Tobacco Use Cessation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Smoking cessation support for patients with rheumatologist diseases is an underestimated issue. In the previous prospective cohort study the investigators determined that with the brief cessation interventions 63.5% of smokers with rheumatologic diseases were willing to quit and the rest 36.4% were not willing. Among the willing group the highest quit rate was detected in the group that admitted to smoking cessation clinic. Therefore to increase the willingness to quit as well as to increase the Access to evidence based tobacco cessation support using new comminication technologies can be relevant. Investigators' aim in this study is to examine the effect of including WhatsApp in the routine smoking cessation practices on the quitting success of active smokers with rheumatic diseases who apply to the Rheumatology outpatient clinic.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06219551
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tobacco Use Cessation
Currently open trials in the same condition.
- NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting
- NCT07148232 — Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness · Phase 4 · recruiting
- NCT07020273 — CONNECT Cancer Survivors With Tobacco Treatment · NA · recruiting
- NCT06883162 — Cannabis-Tobacco Co-Use Treatment Study · Phase 3 · recruiting
- NCT06881069 — Reach Through Equitable Implementation in Utah · NA · recruiting
Other Recep Tayyip Erdogan University Training and Research Hospital trials
Trials by the same sponsor.
- NCT07427095 — The Relationship Between Ultra-Processed Food Consumption and Oral Health · not yet recruiting
- NCT07427069 — Chronic Kidney Disease Associated Diet · not yet recruiting
- NCT07462104 — Metabolic Syndrome Associated Diet · not yet recruiting
- NCT07354815 — Metabolic Syndrome-Associated Periodontal Inflammatory Surface Area · not yet recruiting
- NCT07287540 — Anti-inflammatory Nutrition on the Outcomes of Non-surgical Periodontal Therapy · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06219551 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Recep Tayyip Erdogan University Training and Research Hospital
- Last refreshed: 25 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06219551.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing